Suspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration

Journal of Pharmacy Practice

Volumn 23, Issue 1, 2010, Pages 69-73

  Stoner, Steven C ^a   Berry, Amy ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Northwest Missouri Psychiatric Rehabilitation Center   (United States)

Author keywords

Clozapine; Neuroleptic malignant syndrome; NMS; Quetiapine

Indexed keywords

BROMOCRIPTINE; CEFTRIAXONE; CLONAZEPAM; CLOZAPINE; DANTROLENE; DOCUSATE CALCIUM; DOXYCYCLINE; FERROUS SULFATE; GEMFIBROZIL; GLIBENCLAMIDE; LEVOFLOXACIN; LEVOTHYROXINE; LOXAPINE; METOPROLOL; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; ATAXIA; BEDTIME DOSAGE; CASE REPORT; COGNITION; DELUSION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GAIT DISORDER; HUMAN; HYPOTHYROIDISM; INFECTION; LONG TERM CARE; MALE; MENTAL HEALTH CARE; MYOKYMIA; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOSIS; SEPTICEMIA; SINGLE DRUG DOSE; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 77949370700     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190009333412     Document Type: Article

References (23)

1. Farver DK. Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opin Drug Saf. 2003;2:21-35.
2. Reeves RR, Torres RA, Liberto V, Hart RH. Atypical neuroleptic malignant syndrome associated with olanzapine. Pharmacotherapy. 2002;22:641-644.
3. Stanfield SC, Privette T. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. J Emerg Med. 2000;19:355-357.
4. Trayer JS, Fidler DC. Neuroleptic malignant syndrome related to use of clozapine. J Am Osteopath Assoc. 1998;98:168-169.
5. Hasen S, Buckley P. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. Am J Psychiatry. 1998;155:1113-1116.
6. Bourgeois JA, Babine S, Meyerovich M, Doyle J. A case of neuroleptic malignant syndrome with quetiapine. J Neuropsychiatry Clin Neurosci. 2002;14:87.
7. Tofler IT, Ahmed B. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome. J Clin Psychopharmacol. 2003;23: 672-674.
8. Stanley AK, Hunter J. Possible neuroleptic malignant syndrome with quetiapine. Br J Psychiatry. 2000; 176:497.
9. Matsumoto R, Kitabayashi Y, Nakatomi Y, Tsuchida H, Fukui K. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine. Am J Psychiatry. 2005; 162:812.
10. DasGupta K, Young A. Clozapine induced neuroleptic malignant syndrome. J Clin Psychiatry. 1991;52:105-107.
11. Borovicka MC, Bond LC, Gaughan KM. Ziprasidone and lithium induced neuroleptic malignant syndrome. Ann Pharmacother. 2006;40:139-142.
12. Ozen ME, Yumru M, Savas HA, Cansel N, Herken H. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. World J Biol Psychiatry. 2007;8:42-44.
13. Chakraborty N, Johnston T. Aripiprazole and neuroleptic malignant syndrome. Int Clin Psychopharmacol. 2004;19: 351-353.
14. Addonizio G. Neuroleptic malignant syndrome: epidemiology, clinical presentation, diagnosis, and treatment options. Essent Psychopharmacol. 1997;1:333-407.
15. Lazarus A. The neuroleptic malignant syndrome: a review. Can J Psychiatry. 1986;31:670-674.
16. Kogoj A, Velikonja I. Olanzapine induced neuroleptic malignant syndrome-a case review. Hum Psychopharmacol. 2003;18: 301-309.
17. Velamoor VR. Neuroleptic malignant syndrome recognition, prevention and management. Drug Saf. 1998;19:73-82.
18. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998;49:1163-1172.
19. Farver DK. Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opn Drug Saf. 2003;2:21-35.
20. Caroff SM, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull. 1988;24:25-29.
21. Wells A, Sommi RW, Crismon ML. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intell Clin Pharm. 1988;22:475-479.
22. Rosebush PI, Stewart TD, Gelenberg AJ. Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psych. 1989;50:295-298.
23. Tham JC, Dickson RA. Clozapine induced fevers and 1-year clozapine discontinuation rate. J Clin Psychiatry. 2002;63: 880-884.